{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:37:52Z","timestamp":1792514272600,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1A2A1A15054540"],"award-info":[{"award-number":["2015R1A2A1A15054540"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI15C2920"],"award-info":[{"award-number":["HI15C2920"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12094-016-1608-8","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T09:20:12Z","timestamp":1484558412000},"page":"826-833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Postdiagnostic use of \u03b2-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person\u2013years of follow-up"],"prefix":"10.1007","volume":"19","author":[{"given":"S.-A.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-1977","authenticated-orcid":false,"given":"J.-L.","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-H.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Y.","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"issue":"9","key":"1608_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc3978","volume":"15","author":"SW Cole","year":"2015","unstructured":"Cole SW, Nagaraja AS, Lutgendorf SK, Green PA, Sood AK. Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer. 2015;15(9):563\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"1608_CR2","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042\u201352.","journal-title":"Cancer Res"},{"key":"1608_CR3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2014.02.019","volume":"40","author":"C Kim-Fuchs","year":"2014","unstructured":"Kim-Fuchs C, Le CP, Pimentel MA, Shackleford D, Ferrari D, Angst E, et al. Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav Immun. 2014;40:40\u20137.","journal-title":"Brain Behav Immun"},{"issue":"19","key":"1608_CR4","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","volume":"29","author":"TI Barron","year":"2011","unstructured":"Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: a population-based study. J Clin Oncol. 2011;29(19):2635\u201344.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1608_CR5","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mds616","volume":"24","author":"HM Wang","year":"2013","unstructured":"Wang HM, Liao ZX, Komaki R, Welsh JW, O\u2019Reilly MS, Chang JY, et al. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol. 2013;24(5):1312\u20139.","journal-title":"Ann Oncol"},{"issue":"19","key":"1608_CR6","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/cncr.29392","volume":"121","author":"JL Watkins","year":"2015","unstructured":"Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, et al. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 2015;121(19):3444\u201351.","journal-title":"Cancer"},{"issue":"1","key":"1608_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2125.2011.03980.x","volume":"72","author":"SM Shah","year":"2011","unstructured":"Shah SM, Carey IM, Owen CG, Harris T, Dewilde S, Cook DG. Does beta-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br J Clin Pharmacol. 2011;72(1):157\u201361.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"1608_CR8","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1093\/annonc\/mdt381","volume":"24","author":"BM Hicks","year":"2013","unstructured":"Hicks BM, Murray LJ, Powe DG, Hughes CM, Cardwell CR. Beta-blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort. Ann Oncol. 2013;24(12):3100\u20136.","journal-title":"Ann Oncol"},{"issue":"16","key":"1608_CR9","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.ejca.2014.08.006","volume":"50","author":"J Assayag","year":"2014","unstructured":"Assayag J, Pollak MN, Azoulay L. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer. Eur J Cancer. 2014;50(16):2838\u201345.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1608_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1024491219366","volume":"80","author":"TLt Drell","year":"2003","unstructured":"Drell TLt, Joseph J, Lang K, Niggemann B, Zaenker KS, Entschladen F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat. 2003;80(1):63\u201370.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1608_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijc.20410","volume":"112","author":"K Lang","year":"2004","unstructured":"Lang K, Drell TLt, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer. 2004;112(2):231\u20138.","journal-title":"Int J Cancer"},{"issue":"27","key":"1608_CR12","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1097\/MD.0000000000001097","volume":"94","author":"PY Chang","year":"2015","unstructured":"Chang PY, Huang WY, Lin CL, Huang TC, Wu YY, Chen JH, et al. Propranolol reduces cancer risk: a population-based cohort study. Medicine (Baltimore). 2015;94(27):e1097.","journal-title":"Medicine (Baltimore)"},{"key":"1608_CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2015.02.015","volume":"184","author":"CS Lin","year":"2015","unstructured":"Lin CS, Lin WS, Lin CL, Kao CH. Carvedilol use is associated with reduced cancer risk: a nationwide population-based cohort study. Int J Cardiol. 2015;184:9\u201313.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1608_CR14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0714.2008.00691.x","volume":"38","author":"ZJ Shang","year":"2009","unstructured":"Shang ZJ, Liu K, de Liang F. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma. J Oral Pathol Med. 2009;38(4):371\u20136.","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"1608_CR15","first-page":"334","volume":"41","author":"NE Wolter","year":"2012","unstructured":"Wolter NE, Wolter JK, Enepekides DJ, Irwin MS. Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma. J Otolaryngol Head Neck Surg. 2012;41(5):334\u201344.","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"4","key":"1608_CR16","doi-asserted-by":"crossref","first-page":"e1060","DOI":"10.1542\/peds.2015-2485","volume":"136","author":"DH Darrow","year":"2015","unstructured":"Darrow DH, Greene AK, Mancini AJ, Nopper AJ. Diagnosis and management of infantile hemangioma. Pediatrics. 2015;136(4):e1060\u2013104.","journal-title":"Pediatrics"},{"issue":"2","key":"1608_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1608_CR18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3342\/ceo.2015.8.4.416","volume":"8","author":"M Kong","year":"2015","unstructured":"Kong M, Hong SE. Tumor regression patterns based on follow-up duration in patients with head and neck squamous cell carcinoma treated with radiotherapy or chemoradiotherapy. Clin Exp Otorhinolaryngol. 2015;8(4):416\u201321.","journal-title":"Clin Exp Otorhinolaryngol."},{"issue":"2","key":"1608_CR19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3342\/ceo.2015.8.2.142","volume":"8","author":"SH Moon","year":"2015","unstructured":"Moon SH, Choi JY, Lee HJ, Son YI, Baek CH, Ahn YC, et al. Prognostic value of volume-based positron emission tomography\/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. Clin Exp Otorhinolaryngol. 2015;8(2):142\u20138.","journal-title":"Clin Exp Otorhinolaryngol."},{"issue":"1","key":"1608_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/HJH.0000000000000770","volume":"34","author":"JL Harding","year":"2016","unstructured":"Harding JL, Sooriyakumaran M, Anstey KJ, Adams R, Balkau B, Brennan-Olsen S, et al. Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts. J Hypertens. 2016;34(1):149\u201355.","journal-title":"J Hypertens"},{"issue":"6","key":"1608_CR21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0002-9343(02)01049-5","volume":"112","author":"E Grossman","year":"2002","unstructured":"Grossman E, Messerli FH, Boyko V, Goldbourt U. Is there an association between hypertension and cancer mortality? Am J Med. 2002;112(6):479\u201386.","journal-title":"Am J Med"},{"issue":"4","key":"1608_CR22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.111.189258","volume":"59","author":"T Stocks","year":"2012","unstructured":"Stocks T, Van Hemelrijck M, Manjer J, Bjorge T, Ulmer H, Hallmans G, et al. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension. 2012;59(4):802\u201310.","journal-title":"Hypertension"},{"issue":"7","key":"1608_CR23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00004872-199816070-00006","volume":"16","author":"A Rosengren","year":"1998","unstructured":"Rosengren A, Himmelmann A, Wilhelmsen L, Branehog I, Wedel H. Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens. 1998;16(7):933\u201340.","journal-title":"J Hypertens"},{"issue":"4","key":"1608_CR24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00004872-200204000-00017","volume":"20","author":"SY Lee","year":"2002","unstructured":"Lee SY, Kim MT, Jee SH, Im JS. Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men. J Hypertens. 2002;20(4):617\u201322.","journal-title":"J Hypertens"},{"issue":"1","key":"1608_CR25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/ggi.12073","volume":"14","author":"G Testa","year":"2014","unstructured":"Testa G, Cacciatore F, Della-Morte D, Mazzella F, Mastrobuoni C, Galizia G, et al. Atenolol use is associated with long-term mortality in community-dwelling older adults with hypertension. Geriatr Gerontol Int. 2014;14(1):153\u20138.","journal-title":"Geriatr Gerontol Int"},{"issue":"6878","key":"1608_CR26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bmj.306.6878.609","volume":"306","author":"DJ Hole","year":"1993","unstructured":"Hole DJ, Hawthorne VM, Isles CG, McGhee SM, Robertson JW, Gillis CR, et al. Incidence of and mortality from cancer in hypertensive patients. BMJ. 1993;306(6878):609\u201311.","journal-title":"BMJ"},{"issue":"17","key":"1608_CR27","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jamainternmed.2013.9071","volume":"173","author":"CI Li","year":"2013","unstructured":"Li CI, Daling JR, Tang MT, Haugen KL, Porter PL, Malone KE. Use of antihypertensive medications and breast cancer risk among women aged 55\u201374\u00a0years. JAMA Intern Med. 2013;173(17):1629\u201337.","journal-title":"JAMA Intern Med."},{"issue":"7","key":"1608_CR28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0895-7061(96)00219-1","volume":"9","author":"JR Daling","year":"1996","unstructured":"Daling JR. Calcium channel blockers and cancer: is an association biologically plausible? Am J Hypertens. 1996;9(7):713\u20134.","journal-title":"Am J Hypertens"},{"issue":"1","key":"1608_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","volume":"12","author":"S Bangalore","year":"2011","unstructured":"Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324, 168 participants from randomised trials. Lancet Oncol. 2011;12(1):65\u201382.","journal-title":"Lancet Oncol."},{"issue":"6","key":"1608_CR30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1200\/JCO.2010.31.8311","volume":"29","author":"LG Morris","year":"2011","unstructured":"Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2011;29(6):739\u201346.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-016-1608-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-016-1608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-016-1608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T07:11:56Z","timestamp":1497337916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-016-1608-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1007\/s12094-016-1608-8","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]}}}